Ethnopharmacological Study of Medicinal Plants in New South Wales

N. Brouwer, Q. Liu, D. Harrington, M. Collins, J. Kohen, S. Vemulpad, J. Jamie

 


[intro] [from traditional to modern medicine] [ethnobotanical study] [database] [biological and chemical investigations] [extraction and isolation] [antimicrobial assays] [neurological assays] [results] [acknowledgements]

[ Joanne Jamie ]   [ Jim Kohen ]   [ Subra Vemulpad ]   [ Macquarie University ]


antimicrobial assays


The main focus is on plants that have traditionally been used to treat ailments of a bacterial or fungal origin. Four complementary assays are carried out against the human pathogens S. aureus, P. aeruginosa, E. coli and C. albicans.
  1. disc diffusion assay

  • small paper disc impregnated with the test compound
  • placed on an agar plate inoculated with microbes
  • test compound diffuses through the agar which gives a concentration gradient in the agar
  • if inhibitory concentrations are reached, there will be no growth of the microbes, which can be seen as a clear zone around the disc

  1. broth dilution assay

  • microbes incubated with different concentrations of test compounds
  • growth can be seen visibly or by measuring the turbidity
  • plating the solutions out on agar plates, counting colonies after incubation (distinguish between microbiostatic and microbicidal)
  1. Resazurin assay

  • based on the reduction of blue Resazurin to pink Resorufin
  • reduction by microbial dehydrogenase enzymes
  • colour change is visible, absorbance can be measured at 505 nm

Resazurin assay

active compounds

non-active compounds

  1. Fluorescein Diacetate assay

  • based  on the hydrolysis of colourless fluorescein diacetate (FDA) into yellow-green fluorescein

  • hydrolysis by non-specific esterases found in healthy, growing microbes

  • fluorescence measured at 405 nm excitation and 520 nm emission

  • microbes incubated with the test compounds overnight, FDA added and fluorescence measured

FDA assay

      active       non-active

 

neurological assays

  • plants traditionally used for treatment of pain, anxiety, depression and memory or sleep loss

  • tested on GABA and nicotinic acetylcholine receptors

  • Xenopus (frog) oocytes, injected with mRNA or cDNA, express membrane-bound neurotransmitter receptors

  • treated with extracts or pure compounds

  • neurological activity of the extracts assessed by the magnitude of an electrical response using two electrode voltage clamps

Oocyte with two electrodes

© Erwin Sigel at www.cx.unibe.ch/~sigel/_xenopicts.html

 

results

  • databases have been established for 2 communities

  • the ethnobotanical studies are well under way

  • isx plants have been extracted

  • all plants used traditionally to treat sores show antimicrobial activity

  • fractionation of the extracts are under way to isolate active compounds

  • workshops about ethnopharmacology and protection of indigenous knowledge are being organized for the communities

Details are withheld since they fall under intellectual property rights.

 

acknowledgements

Financial: Australian Institute of Aboriginal and Torres Strait Islander Studies (AIATSIS), Macquarie University Research Grants

Advice: Chris Jones, Centre for Environmental Law, Warawara

Special thanks: Michael Randall, Dale Mercy, Ferlin (Lee) Laurie from the Yaegl community

 

Nynke Brouwer and Qian Liu

[ top of page ]   [ previous page ]


page created by: Nynke Brouwer
last updated: 30.01.2004